Search

Search Funnelback University

Search powered by Funnelback
1 - 10 of 23 search results for `treatment of lupus`
  1. Fully-matching results

  2. Professor David Jayne - Experimental Medicine and Immunotherapeutics…

    https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/
    23 Feb 2024: Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
  3. ADVANCING RESEARCH IN RENAL AUTOIMMUNITY A COLLABORATIVE SYMPOSIUM…

    https://otr.medschl.cam.ac.uk/files/8_emi_autoimmunity_schedule_230120.pdf
    24 Nov 2022: He has organised international collaborative studies to develop consensus classifications of lupus glomerulonephritis, IgA nephropathy and. ... He is responsible for early phase studies of a rapidly expanding portfolio of new compounds under development
  4. History of medicine timeline: 1473 to now | St Catharine's…

    https://www.caths.cam.ac.uk/about-us/history/550/medicine
    Thumbnail for History of medicine timeline: 1473 to now | St Catharine's College, Cambridge 1540: Henry VIII founds the Regius Professorship of Physic, the fourth oldest professorship at Cambridge. ... 2022: Fellow Prof. Rahul Roychoudhuri signs a partnership with AstraZeneca to advance the treatment of lupus.
  5. Thumbnail for Fellow partners with AstraZeneca to advance the treatment of lupus | St Catharine's College, Cambridge Search. Home. Fellow partners with AstraZeneca to advance the treatment of lupus. ... CAR T cell therapy with conventional cytotoxic CD8+ T cells are already having transformative impact in the treatment of patients with cancers of the immune system.
  6. Dr David Jayne | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/jayne
    23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... 33: Smith RM, Jones RB, Jayne DR. Progress in treatment of ANCA-associated vasculitis.
  7. Dr Frances Hall | Sidney Sussex College Cambridge

    https://www.sid.cam.ac.uk/people/dr-frances-hall
    Thumbnail for Dr Frances Hall | Sidney Sussex College Cambridge Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in
  8. PPL number: | Granted: 10 Jun 19 | Amended: ...

    https://www.ubs.admin.cam.ac.uk/system/files/public/provision_of_an_outsourced_drug_discovery_platform_for_diseases_with_an_inflammatory_component_nts_expires2022_redacted.pdf
    13 Sep 2021: i) Avoidance, prevention, diagnosis or treatment of disease, ill-health or abnormality, or theireffects, in man, animals or plants. ... disease. For example we breed mice that have been genetically modified as a model of lupus.
  9. Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…

    https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/
    Thumbnail for Human Antibodies developed for Treatment of Lupus and Anthrax - MRC Laboratory of Molecular Biology 31 Jul 2009: Search this website. Human Antibodies developed for Treatment of Lupus and Anthrax. ... Human Antibodies developed for Treatment of Lupus and Anthrax. Published on.
  10. Human antibody approved for treatment of lupus - MRC Laboratory of

    https://www2.mrc-lmb.cam.ac.uk/human-antibody-approved-for-treatment-of-lupus/
    Thumbnail for Human antibody approved for treatment of lupus - MRC Laboratory of Molecular Biology 11 Mar 2011: Search this website. Human antibody approved for treatment of lupus. Human antibody approved for treatment of lupus. ... Food and Drug Administration. It is the first new drug treatment for lupus in 50 years, and the second human therapeutic antibody,
  11. Insights into how KAP1 silences viral origin DNA in our genomes - MRC …

    https://www2.mrc-lmb.cam.ac.uk/insights-into-how-kap1-silences-viral-origin-dna-in-our-genomes/
    Thumbnail for Insights into how KAP1 silences viral origin DNA in our genomes - MRC Laboratory of Molecular Biology 10 Jul 2019: geographic atrophy, and lupus. ... An improved understanding of how KAP1 functions in healthy individuals could suggest new strategies for treatment of these diseases.

Refine your results

Format

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.